• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用反相高效液相色谱法测定血浆中的利奈唑胺。

Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography.

作者信息

Peng G W, Stryd R P, Murata S, Igarashi M, Chiba K, Aoyama H, Aoyama M, Zenki T, Ozawa N

机构信息

Drug Metabolism Research Laboratories, Pharmacia and Upjohn Co., Kalamazoo, MI 49007, USA.

出版信息

J Pharm Biomed Anal. 1999 Jun;20(1-2):65-73. doi: 10.1016/s0731-7085(98)00310-0.

DOI:10.1016/s0731-7085(98)00310-0
PMID:10704010
Abstract

An HPLC-UV method was developed for assay of linezolid in dog, rat, mouse, and rabbit plasma. Linezolid and the internal standard were extracted on a solid phase cartridge (SPE) and separated on a reversed-phase column (C8, 4.6x150 mm, 5 microm) with 20% acetonitrile in water as mobile phase. The SPE quantitatively recovered linezolid and the internal standard from plasma samples. The chromatographic peak height ratio or peak area ratio based on UV absorbency at 251 nm was used for quantitative analysis. The assay procedures were simple and the assay was specific and had adequate precision and accuracy. Calibration standards with concentrations over the range of 0.01 20 microg/ml were validated for routine sample analysis to support the pharmacokinetic and toxicology studies with linezolid in dog, rat, mouse, and rabbit. Analysis of quality control samples showed the coefficients of variation were usually <10% and the measured and theoretical concentrations differed by <10% in most assays. Linezolid in the plasma samples was stable when stored at below -20 degrees C for at least 63 days, at room temperature (22-23 degrees C) for up to 24 h, and after three freeze-thaw cycles. This HPLC method has been successfully used in multiple laboratories to assay plasma samples from pharmacokinetic and toxicology studies with linezolid in the animal species.

摘要

建立了一种HPLC-UV方法用于测定犬、大鼠、小鼠和兔血浆中的利奈唑胺。利奈唑胺和内标物在固相萃取柱(SPE)上进行萃取,并在反相柱(C8,4.6×150 mm,5μm)上分离,以20%乙腈水溶液为流动相。SPE能从血浆样品中定量回收利奈唑胺和内标物。基于251 nm处紫外吸收的色谱峰高比或峰面积比用于定量分析。该分析方法操作简单,具有特异性,且精密度和准确度良好。浓度范围为0.01~20μg/ml的校准标准品经验证可用于常规样品分析,以支持利奈唑胺在犬、大鼠、小鼠和兔体内的药代动力学和毒理学研究。质量控制样品分析表明,大多数分析中变异系数通常<10%,实测浓度与理论浓度相差<10%。血浆样品中的利奈唑胺在-20℃以下储存至少63天、室温(22-23℃)下储存长达24小时以及经过三次冻融循环后均稳定。该HPLC方法已成功应用于多个实验室,用于分析利奈唑胺在动物体内药代动力学和毒理学研究的血浆样品。

相似文献

1
Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography.采用反相高效液相色谱法测定血浆中的利奈唑胺。
J Pharm Biomed Anal. 1999 Jun;20(1-2):65-73. doi: 10.1016/s0731-7085(98)00310-0.
2
Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection.采用反相高效液相色谱法结合紫外和二极管阵列检测法测定人血清中的利奈唑胺。
Acta Pol Pharm. 2013 Jul-Aug;70(4):631-41.
3
Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection.高效液相色谱法紫外检测法测定人血浆中利奈唑胺的浓度。
Ther Drug Monit. 2010 Aug;32(4):520-4. doi: 10.1097/FTD.0b013e3181d5eeee.
4
Determination of linezolid in growth media by high-performance liquid chromatography with on-line extraction.采用在线萃取高效液相色谱法测定生长培养基中的利奈唑胺。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):104-8. doi: 10.1016/j.jchromb.2007.04.011. Epub 2007 Apr 19.
5
Determination of linezolid in human plasma by LC-MS-MS.采用液相色谱-串联质谱法测定人血浆中的利奈唑胺。
Analyst. 2001 May;126(5):609-14. doi: 10.1039/b100076o.
6
Determination of linezolid in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method.采用全自动萃取法,通过带紫外检测的高效液相色谱法测定血浆和支气管肺泡灌洗液中的利奈唑胺。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):145-50. doi: 10.1016/j.jchromb.2004.09.030.
7
Validation of a simple bioanalytical method for the determination of DRF-6196, a novel oxazolidinone, in mouse plasma: application to a single-dose pharmacokinetic study.一种用于测定新型恶唑烷酮类药物DRF-6196在小鼠血浆中含量的简单生物分析方法的验证:应用于单剂量药代动力学研究
Arzneimittelforschung. 2005;55(4):239-44. doi: 10.1055/s-0031-1296851.
8
A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum.一种用于测定人血清中利奈唑胺的简单等度高效液相色谱法。
J Antimicrob Chemother. 2001 Nov;48(5):605-8. doi: 10.1093/jac/48.5.605.
9
Determination of linezolid in human breast milk by high-performance liquid chromatography with ultraviolet detection.采用高效液相色谱-紫外检测法测定人母乳中的利奈唑胺。
J AOAC Int. 2009 Nov-Dec;92(6):1658-62.
10
High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma.高效液相色谱法用于简单快速测定人血浆中的利奈唑胺。
Biomed Chromatogr. 2006 Aug;20(8):782-6. doi: 10.1002/bmc.597.

引用本文的文献

1
Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.重新评估肾功能损害患者中利奈唑胺的剂量以提高安全性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00605-19. Print 2019 Aug.
2
A validated stability-indicating LC method for the separation of enantiomer and potential impurities of Linezolid using polar organic mode.一种经过验证的稳定性指示液相色谱法,采用极性有机模式分离利奈唑胺的对映体和潜在杂质。
J Pharm Anal. 2012 Aug;2(4):272-278. doi: 10.1016/j.jpha.2012.03.006. Epub 2012 Mar 18.
3
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
超重和肥胖成年患者使用利奈唑胺的群体药代动力学和剂量考虑因素。
Clin Pharmacokinet. 2018 Aug;57(8):989-1000. doi: 10.1007/s40262-017-0606-5.
4
Determination of Residual Solvents in Linezolid by Static Headspace GC.采用静态顶空气相色谱法测定利奈唑胺中的残留溶剂。
J Chromatogr Sci. 2016 Apr;54(4):487-91. doi: 10.1093/chromsci/bmv175. Epub 2015 Dec 10.
5
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.利奈唑胺的治疗药物监测:一项回顾性单中心分析。
Antimicrob Agents Chemother. 2010 Nov;54(11):4605-10. doi: 10.1128/AAC.00177-10. Epub 2010 Aug 23.
6
Penetration of linezolid into rabbit intervertebral discs and surrounding tissues.利奈唑胺在兔椎间盘及其周围组织中的渗透。
Eur Spine J. 2010 Dec;19(12):2149-55. doi: 10.1007/s00586-010-1548-x. Epub 2010 Aug 9.
7
Pharmacological issues of linezolid: an updated critical review.利奈唑胺的药理学问题:更新的批判性评价。
Clin Pharmacokinet. 2010 Jul;49(7):439-47. doi: 10.2165/11319960-000000000-00000.
8
Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion.利奈唑胺和厄他培南在实验性脓胸性胸腔积液中的药代动力学。
J Inflamm (Lond). 2010 May 18;7:22. doi: 10.1186/1476-9255-7-22.
9
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.利奈唑胺在糖尿病足感染中炎症性软组织的药代动力学及渗透情况
Eur J Clin Pharmacol. 2008 Nov;64(11):1093-100. doi: 10.1007/s00228-008-0531-5. Epub 2008 Jul 25.
10
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.克林霉素、达托霉素、多西环素、利奈唑胺、甲氧苄啶-磺胺甲恶唑和万古霉素在小鼠大腿感染及体外药效学模型中对具有诱导型克林霉素耐药性的社区获得性耐甲氧西林金黄色葡萄球菌的活性。
Antimicrob Agents Chemother. 2008 Jun;52(6):2156-62. doi: 10.1128/AAC.01046-07. Epub 2008 Apr 14.